No Data
No Data
No Data
No Data
No Data
Institutional Owners May Consider Drastic Measures as AbCellera Biologics Inc.'s (NASDAQ:ABCL) Recent US$91m Drop Adds to Long-term Losses
Key Insights Given the large stake in the stock by institutions, AbCellera Biologics' stock price might be vulnerable to their trading decisions 50% of the business is held by the top 8 shareholders
Simply Wall StApr 22 06:42 ET
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
Business WireApr 8 12:05 ET
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
Business WireApr 3 16:05 ET
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
Yahoo FinanceMar 19 16:05 ET
AbCellera To Collaborate With Biogen To Discover Therapeutic Antibodies For Neurological Conditions
AbCellera (NASDAQ:ABCL) and Biogen Inc. (NASDAQ:BIIB) have entered into a strategic collaboration to discover antibodies for a novel target that enables the delivery of biotherapeutics to the brain fo
BenzingaMar 11 09:03 ET
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
AbCellera (NASDAQ:ABCL) today announced that its scientists will present four posters with data from its T-cell engager programs and platform at the American Association for Cancer Research (AACR) Annual Meeting 2024,
BusinesswireMar 5 16:30 ET
TrytosaveabitOP PYUN970IHaveChosen: Yeah right! That’s a litter bit more than it’s trading?
PYUN970IHaveChosen TrytosaveabitOP: Watching. Still laughing about this GVH all over the place today.
TrytosaveabitOP PYUN970IHaveChosen: I Stayed away from it! Don’t know why i didn’t like it? But i didn’t. Hehehe
PYUN970IHaveChosen TrytosaveabitOP: Well I did most of the day and then just watched it plummet to 2.56 several times so I couldn’t help myself to grab a few at that price. WeBuy was doing good so I grabbed a few with some SMALL gains.
No Data
No Data